SUNNYVALE, Calif., July 9, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2012 second quarter on Thursday, July 19, 2012, after the close of the market.
The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, July 19, 2012, to discuss the results. To access the live webcast, please visit Cepheid’s website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.
About Cepheid
Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.
CONTACTS: | ||
For Media Inquiries: | For Investor Inquiries: | |
Jared Tipton Cepheid Corporate Communications Tel: (408) 400 8377 communications@cepheid.com | Jacquie Ross Cepheid Investor Relations Tel: (408) 400 8329 | |
SOURCE Cepheid
